Vedanta Biosciences Initiates Phase 2 Study for Lead Rationally-Defined Bacterial Consortium Product Candidate, VE303

Press/Media

Period	17 Dec 2018

Media coverage

Title	Vedanta Biosciences Initiates Phase 2 Study for Lead Rationally-Defined Bacterial Consortium Product Candidate, VE303
Media name/outlet	BioSpace
Country/Territory	United States
Date	17/12/18
URL	https://www.biospace.com/article/releases/vedanta-biosciences-initiates-phase-2-study-for-lead-rationally-defined-bacterial-consortium-product-candidate-ve303/?s=95
Persons	Jeremiah Faith